Authors:
Stock, UA
Wiederschain, D
Kilroy, SM
Shum-Tim, D
Khalil, PN
Vacanti, JP
Mayer, JE
Moses, MA
Citation: Ua. Stock et al., Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures, J CELL BIOC, 81(2), 2001, pp. 220-228
Citation: Jj. Gu et al., Identification of p53 sequence elements that are required for MDM2-mediated nuclear export, MOL CELL B, 21(24), 2001, pp. 8533-8546
Citation: D. Wiederschain et al., Evidence for a distinct inhibitory factor in the regulation of p53 functional activity, J BIOL CHEM, 276(30), 2001, pp. 27999-28005
Citation: Jj. Gu et al., Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has mutation outside of the DNA-binding domain, CANCER RES, 61(4), 2001, pp. 1741-1746
Authors:
Fang, JM
Shing, Y
Wiederschain, D
Yan, L
Butterfield, C
Jackson, G
Harper, J
Tamvakopoulos, G
Moses, MA
Citation: Jm. Fang et al., Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model, P NAS US, 97(8), 2000, pp. 3884-3889
Authors:
LaMontagne, KR
Moses, MA
Wiederschain, D
Mahajan, S
Holden, J
Ghazizadeh, H
Frank, DA
Arbiser, JL
Citation: Kr. Lamontagne et al., Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells, AM J PATH, 157(6), 2000, pp. 1937-1945
Authors:
O'Reilly, MS
Wiederschain, D
Stetler-Stevenson, WG
Folkman, J
Moses, MA
Citation: Ms. O'Reilly et al., Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance, J BIOL CHEM, 274(41), 1999, pp. 29568-29571